OnKure Therapeutics, Inc.

NASDAQ:OKUR

Biotechnology

Healthcare
$2.82 +0.23%

+$0.01 today

Market cap
$114.22M
Beta
0.28
P/E (TTM)
-1.0
EPS (TTM)
-$4.30
52W Low $1.91High $5.38

Volume 0.17M

Average 0.37M

OKUR Account Payables

Amounts the company owes suppliers for goods and services received.

OnKure Therapeutics, Inc.NASDAQ: OKUR

Account Payables · Q1 FY2026 · quarter ended Mar 2026

Account payables rises 370.2% from a year ago

Account payables stood at $11.02M at the end of Q1 FY2026, up 370.2% from a year earlier and up 669.2% from the prior quarter. Over 3 fiscal years it compounded at -17.2% a year.

Context

  • Account payables amounted to 5.5% of total assets at the end of Q1 FY2026, up 3.2 pp from a year earlier.
  • Account payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether account payables keeps rising in the next quarterly balance sheet after a +370.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$11.02M+669.2% QoQ
Last fiscal yearDec 2025
$1.43M-51.7% YoY
Year agoMar 2025
$2.34M+370.2% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+370.2%——
1 year-51.7%——
3-year CAGR-17.2%——
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
1.43M USD
Year-over-year change
-51.7%

Account Payables vs competitors

How OKUR compares with its peers on the latest reported figures

  • OKUR's Mar 2026 account payables of $11.02M is the highest of the 4 companies compared; the peer median is $3.65M.
  • Its year-over-year change of +370.2% is the highest of 4, against a peer median of +10.4%.
  • Account payables amounts to 5.5% of total assets for OKUR, versus a peer median of 14.8%.
OKUR Competitors Peer median
Account Payables for OKUR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OKUROnKure Therapeutics, Inc.Mar 2026$11.02M +370.2%-17.2%5.5%
ATNMActinium Pharmaceuticals, Inc.Jun 2026$8.51M +10.4%—21.2%
PDSBPDS Biotechnology CorporationMar 2026$3.65M +27.7%+43.1%14.8%
XLOXilio Therapeutics, Inc.Mar 2026$1.06M -53.2%+0.5%0.7%
Peer median (excluding OKUR) $3.65M+10.4%+21.8%14.8%

Competitors are the stored peer set for OKUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents124.66M11.54M29.88M110.76M59.05M
Short-term Investments23.01M0000
Net Receivables00000
Inventory00000
Other Current Assets6.06M840K001.79M
Total Current Assets153.73M13.62M33.77M113M60.84M
Property, Plant & Equipment (Net)212K2.05M1.91M1.8M1.01M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets78K329K58K109K273K
Total Non-current Assets290K2.38M1.97M1.9M1.28M
Total Assets154.02M16M35.73M114.91M62.12M
Account Payables02.52M3.42M2.97M1.43M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.2M1.46M1.66M3.17M1.25M
Total Current Liabilities6.2M5.54M7.29M10.53M5.92M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)167K0000
Other Non-current Liabilities444K64.39M129.83M012K
Total Non-current Liabilities611K64.88M130.29M549K12K
Total Liabilities6.81M70.42M137.58M11.08M5.93M
Common Stock3K1K01K1K
Retained Earnings(84.73M)(57.07M)(102.05M)(154.72M)(214.24M)
Accumulated OCI34K0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity147.21M(54.42M)(101.84M)103.83M56.18M
Total Debt0637K674K1.09M549K
Net Debt(124.66M)(10.91M)(29.2M)(109.68M)(58.5M)

OnKure Therapeutics, Inc.

NASDAQ:OKUR

Intrinsic Alpha fair value

Locked

Current Price

$2.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.